We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+15.73%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.4B
AUM Growth
+$1.02B
Cap. Flow
-$761M
Cap. Flow %
-6.65%
Top 10 Hldgs %
38.51%
Holding
1,217
New
80
Increased
450
Reduced
355
Closed
36

Top Buys

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$250M
2
EQIX icon
Equinix
EQIX
+$102M
3
EXR icon
Extra Space Storage
EXR
+$63.2M
4
INVH icon
Invitation Homes
INVH
+$48.9M
5
PEB icon
Pebblebrook Hotel Trust
PEB
+$41.9M

Top Sells

Rank Stock Value
1
VNO icon
Vornado Realty Trust
VNO
+$172M
2
CCI icon
Crown Castle
CCI
+$121M
3
DOC icon
Healthpeak Properties
DOC
+$101M
4
VTR icon
Ventas
VTR
+$100M
5
SBAC icon
SBA Communications
SBAC
+$96.7M

Sector Composition

Rank Sector Weight
1 Real Estate 74.34%
2 Technology 3.93%
3 Industrials 3.02%
4 Financials 2.65%
5 Healthcare 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTRX icon
1076
Quanterix
QTRX
$176M
$4K ﹤0.01%
141
-109
-44% -$2.43K
ZLAB icon
1077
Zai Lab
ZLAB
$2.1B
$4K ﹤0.01%
132
-118
-47% -$3.23K
ITCI
1078
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4K ﹤0.01%
302
– –
RVNC
1079
DELISTED
Revance Therapeutics, Inc.
RVNC
$4K ﹤0.01%
280
+78
+39% +$1.35K
PETQ
1080
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$4K ﹤0.01%
136
+63
+86% +$1.78K
EGRX
1081
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4K ﹤0.01%
82
– –
GTHX
1082
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$4K ﹤0.01%
238
+81
+52% +$1.54K
CCXI
1083
DELISTED
ChemoCentryx, Inc.
CCXI
$4K ﹤0.01%
269
– –
DERM
1084
DELISTED
Dermira, Inc.
DERM
$4K ﹤0.01%
+269
New +$2.24K
AUPH icon
1085
Aurinia Pharmaceuticals
AUPH
$1.99B
$3K ﹤0.01%
464
– –
COLL icon
1086
Collegium Pharmaceutical
COLL
$1.16B
$3K ﹤0.01%
180
– –
CRNX icon
1087
Crinetics Pharmaceuticals
CRNX
$8.87B
$3K ﹤0.01%
153
-67
-30% -$1.65K
CBIO
1088
Crescent Biopharma
CBIO
$632M
$3K ﹤0.01%
3
+1
+50% +$1.15K
LXRX icon
1089
Lexicon Pharmaceuticals
LXRX
$1.01B
$3K ﹤0.01%
583
– –
OPTN
1090
DELISTED
OptiNose
OPTN
$3K ﹤0.01%
+18
New +$2.09K
PRQR icon
1091
ProQR Therapeutics
PRQR
$244M
$3K ﹤0.01%
246
-104
-30% -$1.55K
PRTA icon
1092
Prothena Corp
PRTA
$456M
$3K ﹤0.01%
+212
New +$2.65K
REPL icon
1093
Replimune Group
REPL
$718M
$3K ﹤0.01%
201
-149
-43% -$1.86K
SIGA icon
1094
SIGA Technologies
SIGA
$226M
$3K ﹤0.01%
511
-289
-36% -$1.94K
SLDB icon
1095
Solid Biosciences
SLDB
$789M
$3K ﹤0.01%
20
– –
VYGR icon
1096
Voyager Therapeutics
VYGR
$182M
$3K ﹤0.01%
178
– –
TECX
1097
Tectonic Therapeutic
TECX
$585M
$3K ﹤0.01%
13
-8
-38% -$1.46K
ACOR
1098
DELISTED
Acorda Therapeutics
ACOR
$3K ﹤0.01%
2
– –
ELOX
1099
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$3K ﹤0.01%
6
-4
-40% -$1.94K
FLXN
1100
DELISTED
Flexion Therapeutics, Inc.
FLXN
$3K ﹤0.01%
207
– –
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q1 2019 Portfolio in Review

As of Q1 2019, Daiwa Securities Group held 1,217 positions worth $11.4B, up 9.8% from $10.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group withdrew a net $761M in Q1 2019, closing 36 positions and reducing 355 holdings. Its most notable exit was CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 74% of assets, down from 75% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Steris worth $13.7M.

  • Daiwa Securities Group's largest Q1 2019 buy was Steris: 106,969 shares worth $13.7M.
  • Daiwa Securities Group added most to Public Storage in Q1 2019, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2019 reduction was Vornado Realty Trust, cutting an estimated $172M.
  • Daiwa Securities Group fully exited CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S in Q1 2019, selling an estimated $15.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $11.4B portfolio in Q1 2019.
  • Daiwa Securities Group opened 80 new positions and closed 36 in Q1 2019.
  • Daiwa Securities Group's portfolio value rose 9.8% quarter-over-quarter to $11.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2019, filed 26 Apr 2019.